Pyridoxine as a template for the design of antiplatelet agents

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 18, 2004, Pages 4747-4750

  Zhang, Wenlian ^a   Yao, John ^a   Pham, Vinh ^a   Whitney, Tara ^a   Froese, Doug ^a   Friesen, Albert ^b   Stang, Linda ^c   Xu, Chen ^d   Shuaib, Ashfaq ^d   Diakur, James M ^a   Haque, Wasim ^a  

^a Canam Bioresearch Inc   (Canada)

^b Medicure International Inc   (Canada)

^c UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antiischemic; Antiplatelet; Pyridoxine

Indexed keywords

ANTITHROMBOCYTIC AGENT; NEUROPROTECTIVE AGENT; PYRIDOXINE;

ARTICLE; DRUG DESIGN; DRUG SYNTHESIS; HEART PROTECTION; NEUROPROTECTION;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PYRIDOXINE; RATS; RATS, WISTAR; SWINE;

EID: 8544263834     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.06.079     Document Type: Article

References (29)

1. P. Clutton, J.D. Folts, and J.E. Freedman Pharmacol. Res. 44 2001 255
2. H. Ni, and J. Freedman Transfus. Apheresis Sci. 28 2003 257
3. K.J. Clemetson A. Michelson Platelets 2002 Academic Press San Diego 65 84
4. K.A. Ault, C.P. Cannon, J. Mitchell, J. McCahan, R.P. Tracy, W.F. Novotny, J.D. Reimann, and E. Braunwald J. Am. Coll. Cardiol. 33 1999 634
5. G. Helft, J.I. Osende, S.G. Worthley, A.G. Zaman, O.J. Rodriguez, E.I. Lev, M.E. Farkouh, V. Fuster, J.J. Badimon, and J.H. Chesebro Arterioscler. Thromb. Vasc. Biol. 20 2000 2316
6. K. Subbarao, J. Kuchibholta, and V.V. Kakkar Biochem. Pharmacol. 28 1979 531
7. S. Krishnamurthi, J. Westwick, and V.V. Kakkar Thromb. Haemostas. 48 1982 136
8. C.H. Gammell J. Lab. Clin. Med. 131 1998 84
9. N.W. Schoene, P. Chanmugam, and R.D. Reynolds Am. J. Clin. Nutr. 43 1986 825
10. V. van Wyk, H.G. Luus, and A. du P. Heyns Thromb. Res. 66 1992 657
11. S.-J. Chang, H.-J. Chuang, and H.-H. Chen J. Nutr. Sci. Vitaminol. 45 1999 471
12. B. Imperiali, and R.S. Roy J. Org. Chem. 60 1995 1891
13. Haque, W. U.S. Patent 6,417,204 B1, 2002
14. W. Korytnyk, and M. Ikawa Methods Enzymol. 18A 1970 524
15. V. Pham, W. Zhang, V. Chen, T. Whitney, J. Yao, D. Froese, A.D. Friesen, J.M. Diakur, and W. Haque J. Med. Chem. 46 2003 3680
16. A. Pinner Die Imidoaether und ihre Derivate 1892 Oppenheim Berlin p 1
17. 4, pH 3.0. The retention time for 16 was 14.3 min; purity: 99.3%
18. R. Ferrari, P. Pepi, F. Ferrari, F. Nesta, M. Benigno, and O. Visioli Am. J. Cardiol. 82 5A 1998 2K
19. M. Dellborg, J. Herlitz, M. Risenfors, and K. Swedberg Int. J. Cardiol. 40 1993 167
20. Dhalla, N. S.; Sethi, R.; Dakshinamurti, K. U.S. Patent 6,043,259
21. T. Alexy, A. Toth, Z. Marton, B. Horvath, K. Koltai, G. Feher, G. Kesmarky, T. Kalai, K. Hideg, B. Sumegi, and K. Toth J. Cardiovasc. Pharmacol. 43 2004 423
22. K. Zacharowski, B. Blackburn, and C. Thiemermann Eur. J. Pharmacol. 418 2001 105
23. C. Wang, T. Yang, and A. Shuaib J. Neurosci. Methods 109 2001 147
24. Experimental details of the cerebral ischemia study will be presented elsewhere
25. Y. Yang, A. Shuaib, and Q. Li J. Neurosci. Methods 84 1998 9
26. Y. Mehri, P. Provost, P. Chauvet, J.-F. Theoret, M.L. Phillips, and J.-G. Latour Arterioscler. Thromb. Vasc. Biol. 19 1999 372
27. L. Badimon, V. Turitto, J.A. Rosemark, J.J. Badimon, and V. Fuster J. Lab. Clin. Med. 110 1988 706
28. The full details of this biological study will be reported elsewhere
29. M.L. Rand, R. Leung, and M.A. Packham Transfus. Apheresis Sci. 28 2003 307